Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04941716

Phase2, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Seattle WA, Vancouver, Calgary, Edmonton, Palo Alto CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase1, Phase2, Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Seattle WA, Pittsburgh PA, Tampa FL
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 1 - 60

Code: NCT03970096

Phase2, Recruiting

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

for
Advanced/Metastatic Solid Tumors
Location: Seattle WA, Duarte CA, Irvine CA, Scottsdale AZ,
Sponsor: Adagene Inc

Sex: All

Age: 18+

Code: NCT05405595

Phase1, Phase2, Recruiting

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

for
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8,
Location: Seattle WA, Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT05081024

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Seattle WA, Stanford CA, Aurora CO, Chicago IL,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase1, Phase2, Recruiting

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

for
Relapsed Adult AML, Primary Refractory Acute Myeloid Leukemia,
Location: Seattle WA, Portland OR, Stanford CA, Denver CO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05237258

Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Duarte CA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase1, Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

for
Ovarian Cancer, Epithelial, Gastric Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05107674

Phase1, Recruiting

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT04329065

Phase2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Seattle WA, Los Angeles CA, Cerritos CA, Orange CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase1, Phase2, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Seattle WA, Vancouver, Edmonton, Sacramento CA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase1, Phase2, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant
Location: Seattle WA, Portland OR, Vancouver, Edmonton,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase3, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Seattle WA, Sacramento CA, San Francisco CA,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Seattle WA, Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase3, Recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

for
Solid Tumor
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04939610

Phase1, Phase2, Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

for
Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 50

Code: NCT03980769

Phase2, Recruiting

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

for
Advanced Osteosarcoma, Recurrent Osteosarcoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 1 - 70+

Code: NCT07227571

Phase1, Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,
Location: Seattle WA, Salt Lake City UT, Dallas TX, Chicago IL,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT05765812

Phase1, Phase2, Recruiting

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

for
Locally Advanced Malignant Solid Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04515810

Recruiting